CONMED Corporation

Company Profile

CONMED Corporation had its IPO on 1987-07-23 under the ticker symbol CNMD.

The company operates in the Healthcare sector and Medical Devices industry. CONMED Corporation has a staff strength of 4,100 employees.

Stock update

Shares of CONMED Corporation opened at $108.24 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $107.04 - $109.06, and closed at $107.73.

This is a -1.13% slip from the previous day's closing price.

A total volume of 398,670 shares were traded at the close of the day’s session.

In the last one week, shares of CONMED Corporation have slipped by -2.49%.

CONMED Corporation's Key Ratios

CONMED Corporation has a market cap of $3.88 billion, indicating a price to book ratio of 3.877 and a price to sales ratio of 2.4615.

In the last 12-months CONMED Corporation’s revenue was $1.10 billion with a gross profit of $575.75 million and an EBITDA of $148.11 million. The EBITDA ratio measures CONMED Corporation's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, CONMED Corporation’s operating margin was 7.24% while its return on assets stood at 2.42% with a return of equity of -12.16%.

In Q1, CONMED Corporation’s quarterly earnings growth was a negative -87.4% while revenue growth was a positive 21.9%.

CONMED Corporation’s PE and PEG Ratio

Forward PE

27.027

Trailing PE

0

PEG

5.29

Its diluted EPS in the last 12-months stands at $-3.27 per share while it has a forward price to earnings multiple of 27.027 and a PEG multiple of 5.29. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into CONMED Corporation’s profitability.

CONMED Corporation stock is trading at a EV to sales ratio of 3.538 and a EV to EBITDA ratio of 57.6193. Its price to sales ratio in the trailing 12-months stood at 2.4615.

CONMED Corporation stock pays annual dividends of $0.8 per share, indicating a yield of 0.65% and a payout ratio of 30.65%.

Balance sheet and cash flow metrics

Total Assets

$2.32 billion

Total Liabilities

$320.69 million

Operating Cash Flow

$-4254000.00

Capital Expenditure

$4.25 million

Dividend Payout Ratio

30.65%

CONMED Corporation ended 2024 with $2.32 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $2.32 billion while shareholder equity stood at $752.45 million.

CONMED Corporation ended 2024 with $0 in deferred long-term liabilities, $320.69 million in other current liabilities, 313000.00 in common stock, $408.34 million in retained earnings and $815.50 million in goodwill. Its cash balance stood at $26.49 million and cash and short-term investments were $26.49 million. The company’s total short-term debt was $69,693,000 while long-term debt stood at $995.28 million.

CONMED Corporation’s total current assets stands at $610.09 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $213.18 million compared to accounts payable of $76.68 million and inventory worth $335.37 million.

In 2024, CONMED Corporation's operating cash flow was $-4254000.00 while its capital expenditure stood at $4.25 million.

Comparatively, CONMED Corporation paid $0.31 in dividends in 2024.

Other key metrics

Current Trading Price

$107.73

52-Week High

$129.65

52-Week Low

$70.7802

Analyst Target Price

$126.14

CONMED Corporation stock is currently trading at $107.73 per share. It touched a 52-week high of $129.65 and a 52-week low of $129.65. Analysts tracking the stock have a 12-month average target price of $126.14.

Its 50-day moving average was $117.81 and 200-day moving average was $108.39 The short ratio stood at 10.47 indicating a short percent outstanding of 0%.

Around 58.7% of the company’s stock are held by insiders while 12032.4% are held by institutions.